false
OasisLMS
Login
Catalog
SHM Converge Scientific Abstract ePoster Gallery
Therapeutic Cul-De-Sac: Refractory Cancer-Associat ...
Therapeutic Cul-De-Sac: Refractory Cancer-Associated Thrombosis Complicated by Heparin-Induced Thrombocytopenia in Advanced Pancreatic Cancer
Back to course
Pdf Summary
A 67-year-old woman presented with pleuritic chest pain and dyspnea and was found to have DVTs and pulmonary emboli. Further evaluation revealed metastatic pancreatic cancer with KRAS, MYC, and CDKN2A/B alterations. She underwent mechanical thrombectomy and was initially discharged on apixaban.<br /><br />Her course was marked by repeated thromboembolic recurrences despite multiple anticoagulation strategies. After a second admission for PE extension, she was treated with heparin, but developed heparin-induced thrombocytopenia (HIT), requiring a switch to argatroban and discharge on fondaparinux. She later started mFOLFIRINOX, but was rehospitalized for further PE progression. Additional anticoagulation changes included argatroban, warfarin, and then dabigatran due to unstable INR control. On a fourth admission, she developed extensive clot burden as well as arterial thrombi and strokes while receiving argatroban. She ultimately chose hospice care and died.<br /><br />This case highlights the extreme hypercoagulability associated with advanced pancreatic adenocarcinoma, particularly KRAS-mutated disease. It also demonstrates how cancer-associated thrombosis can become refractory even with multiple anticoagulants and be further complicated by HIT. The report emphasizes the poor prognosis linked to malignancy-driven thrombosis and the importance of recognizing when recurrent thromboembolic events persist despite optimal treatment, prompting timely transition to comfort-focused care.
Asset Subtitle
Parker Meeks
Meta Tag
Author List
Lalitha Ranga, Morgan Rachlin, Nicholas Scelzi, Parker Meeks
Category
Clinical Vignettes
Concept
Pancreatic Adenocarcinoma
Concept
Cancer-Associated Venous Thromboembolism
Concept
Thromboembolism
Concept
Heparin-Induced Thrombocytopenia
Concept
Metastatic Disease
Distinguished
Non-Finalist
Presenter Organization
Department of Internal Medicine, New York Institute of Technology College of Osteopathic Medicine at Arkansas State University, Jonesboro, AR 72401
Presenting Author
Parker Meeks
Track
Adult
Keywords
pancreatic cancer
thrombosis
pulmonary embolism
deep vein thrombosis
hypercoagulability
KRAS mutation
heparin-induced thrombocytopenia
anticoagulation
mechanical thrombectomy
hospice care
Pancreatic Adenocarcinoma
Cancer-Associated Venous Thromboembolism
Thromboembolism
Heparin-Induced Thrombocytopenia
Metastatic Disease
×
Please select your language
1
English